authors
-
Andrzej Borkowski
- Klinika i Katedra Urologii Akademii Medycznej w Warszawie
summary
- Rationale (based on results of prospective, multicenter clinical trials) for radical treatment
- modalities currently applied in early stages of prostate cancer has not yet been elaborated. No
- markers facilitating treatment decision in every individual patient are available so far. Thus
- extreme therapeutic managements may be observed: from an aggresive attitude, proposing
- radical treatment in every case, to watchful waiting, offering follow up and hormonal
- manipulation on time of progression.
- An algorithm proposing potential decision is presented, depending on patient's age, serum
- PSA level and results of systematic, spatially oriented, transrectal ultrasound guided core
- biopsies of prostate.
references
- 1. Adolfsson J.a Carstensen J., Lowhagen T.: Defferred treatment in Clinically localised
- prostatic carcinoma. Br. J. Urol. 1992, 69, 183. ?2. Bagshaw M.A., Cox R.X., Ranback J.E.:
- Radiation therapy for localised prostate cancer. Justification by long-term follow up. Urol. Clin.
- North. Am. 1990, 17, 787. ? 3. Cantrell B.B., De Klerk D.P., Eggleston J.C., Boinott J.K.,
- Walsh P.C.: Pathological factors that influence prognosis in stage A prostatic cancer: The
- influence of extent versus grade. J. Urol. 1981, 125, 516. ? 4. Chisholm G.D., Rana A.: Is the
- outcome of conservative management for localised prostate cancer acceptable? An overview.
- Eur. Urol. 1993, 24 (suppl 2), 64. ? 5. Chybowski F., Larson Keller J., Bergstralh E., Oesterling
- J.\ Predicting radionucleide bone scan findings in patients with newly diagnosed, untreated
- prostate cancer: prostate specific antigen is superior to other clinical parameters. J. Urol. 1991,
- 145, 313. ? 6. Cooner W.H.: Editorial: prostate cancer. J. Urol. 1994,151, 103. ? 7. Dalkin B.,
- Ahman F., Southtoick P., Bottacini M.\ Derrivation of normal prostate specific antigen (PSA) by
- age. AUA 88 th Annual Meeting. 1993, J. Urol. 1993, 149,413A. ? 8. DanellaJ.F., de Kernion
- J., Smith R.B., Steckel J.\ The contemporary incidence of lymph node metastases in prostate
- cancer: implications for laparoscopic lymph node dossection. J. Urol. 1993, 149, 1488. ?
- 9. Epstein JJ., Paul G., Eggleston J.C., Walsh P.C.: Prognosis of unterated stage Al prostatic
- carcinoma: A study of 94 cases with extended follow-up. J. Urol. 1986,136, 837. ? 10. Epstein
- J.I., Walsh P.C., Brendler Ch.B.: Radical prostatectomy for impalpable prostate cancer: the
- Johns Hopkins experience with tumors found on transurethral resection (stages Tl a i Tlb) on
- needle biopsy (stage Tle). J. Urol. 1994, 152, 1721.
- 11. Flanigan R.C., Catalona W.J., Richie J.P., Ahmann F.R., Hudson M.A., Scardino
- P.T., de Kernion J.B., Ratlif T.L., Kavoussi L.R., Dalkin B.L., Waters W.B., McFarlane M.T.,
- Soutwick P.C.: Accuracy of digital rectal examination and transrectal ultrasonography in
- localizing prostate cancer. J. Urol. 1994, 152, 1506. ? 12. Freiha F.S., Bagshaw M.A.:
- Carcinoma of the prostate: Results of postirradiation biopsy. Prostate 1984, 5, 19. ? 13. Gerber
- G.j Rukstalis D., Chodak G.: Correlation of prostate specific antigen and tumor grade with nodal
- status in man with Clinically localised prostate cancer. AUA 88th Annual Meeting. J. Urol.
- 1993, 149, 448A. ? 14. Heaney J.A., Chang H.C., Daly J.J., Prout G.R.Jr.: Prognosis of
- Clinically undiagnosed prostatic carcinoma and the influence of endocrine therapy. J. Urol.
- 1977, 118, 283. ? 15. Johansson J.E., Andersson S.O., Krusemo U.B., Adami H.O., Bergstrom
- R.,Kraaz W.: Natural history of localised prostatic cancer. Lancet 1989,1,799. ? 16. Johanson
- J.E., Adami H.O., Anderson S.O., Bergstrom R., Holmberg L., Krusemo U.B.: High 10-year
- survival rate in patients with early, untreated prostatic cancer. JAMA 1993, 267, 2191. ? 17.
- Mclntire T.L., Murphy W.M., CoonJ.S.: The Prognostic value of DNA ploidy combined with
- histologic substaging for incidental carcinoma of the prostate gland. Am. J. Clin. Pathol. 1988,
- 89, 370. ? 18. Partin A.W., Lee B.R., Carmichael M., Walsh P.C., Epstein J.I.: Radical prostatectomy for high grade disease: a reevaluation 1994. J. Urol. 1994, 151, 1583. ? 19.
- Rastry V., Boccon-Gibod L.A., Billebaud T., Dauge M.C, Haab F., Delmas V., Boccon-Gibod
- L.M.: Systematic random biopsies accurately predict extracapsular extension of prostate cancer
- md persistant/recurent detectable PSA after radical prostatecomy. Abstract Book of XI
- Congress EUA. Berlin 1994, abstr. 371. ? 20. Rukstalis D.B., Gerber G.S., Yogelzang N.J.,
- HarafD.J., Straus F.H., Chodak G.W.: Laparoscopic pelvic lymph node dissection: a review of
- 103 consecutive cases. J. Urol. 1994, 151, 670.
- 21. Scardino PT.: Early detection of prostate cancer. Urol. Clin. North. Am. 1989, 16,
- 635. ? 22. Seideman H., Mushinski M.H., Gelb S.K., Siherberg E.: Probabilities of eventually
- dercloping or dying of cancer ? United States. 1985, 35, 36. ? 23. Schroder F.H.: The limits of
- surgery in the cure of prostatic carcinoma E.B.U. European Update series. 1992 Vo. 1, Nr 3.
- ? 24. Stamey T.A., McNeal J.E., Freiha F.S., Redwine E.: Morphometric and clinical studies oo 68 consecutive radical prostatectomies. J. Urol. 1988,139,1235. ?25. Wu T.T., Chen K.K. Hmang J-K., Lee Y-H., Chen M-T., Chang L.S.: Prediction of lymphatic spreading in
- prosanc cancer by prostate specific antigen and Gleason score. Eur. Urol. 1994, 26, 202.
|